139 related articles for article (PubMed ID: 36918840)
1. The expression, immune infiltration, prognosis, and experimental validation of OSBPL family genes in liver cancer.
Tian K; Ying Y; Huang J; Wu H; Wei C; Li L; Chen L; Wu L
BMC Cancer; 2023 Mar; 23(1):244. PubMed ID: 36918840
[TBL] [Abstract][Full Text] [Related]
2. Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma.
Chou CW; Hsieh YH; Ku SC; Shen WJ; Anuraga G; Khoa Ta HD; Lee KH; Lee YC; Lin CH; Wang CY; Wang WJ
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829830
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and biological function value of OSBPL3 in colorectal cancer analyzed by multi-omic data analysis.
Wang C; He Y; He Y; Liang W; Zhou C; Wu M; Meng Z; Li W; Cao J
BMC Gastroenterol; 2023 Aug; 23(1):270. PubMed ID: 37550605
[TBL] [Abstract][Full Text] [Related]
4. Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer.
Hu Q; Masuda T; Koike K; Sato K; Tobo T; Kuramitsu S; Kitagawa A; Fujii A; Noda M; Tsuruda Y; Otsu H; Kuroda Y; Ito S; Oki E; Mimori K
Sci Rep; 2021 Sep; 11(1):19178. PubMed ID: 34584127
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma.
Su Y; Xue C; Gu X; Sun Y; Zhang R; Li L
Heliyon; 2023 Jun; 9(6):e17223. PubMed ID: 37389070
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value and Potential Mechanisms of Oxysterol-Binding Protein Like 3 (OSBPL3) in Human Tumors.
Hao N; Zhou Y; Li Y; Zhang H; Wang B; Liu X; Ren Y; He J; Zhou C; Tang X
Front Mol Biosci; 2021; 8():739978. PubMed ID: 34738015
[TBL] [Abstract][Full Text] [Related]
7. The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis.
Zhang M; Meng L; Zhang Z; Wu J; Chen X; Wang Y; He J
BMC Med Genomics; 2022 Dec; 15(1):259. PubMed ID: 36517805
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
10. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
[TBL] [Abstract][Full Text] [Related]
11. A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors.
Fang H; Sheng S; Chen B; Wang J; Mao D; Han Y; Liu Y; Wang X; Gui S; Zhang T; Zhang L; Li C; Hu X; Deng W; Liu X; Xu H; Xu W; Wang X; Liu R; Kong W
Front Immunol; 2022; 13():826337. PubMed ID: 35251007
[TBL] [Abstract][Full Text] [Related]
12. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
13. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
14. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
17. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma.
Jiang X; Chen X; Huang X; Wang C; Wang C; Pan C; Cho WC; Nie Z; Pu J; Wang W
Aging (Albany NY); 2022 Jun; 14(19):7774-7793. PubMed ID: 35661004
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma.
Fan L; Tang Y; Li J; Huang W
Sci Rep; 2023 Jan; 13(1):335. PubMed ID: 36611046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
